Taken together, these results suggest that sST2 may inhibit IL-33-induced monocyte infiltration and M2a polarization of the infiltrated cells, thereby reducing the stimulatory effects of TAMs on tumour angiogenesis, invasion and metastasis. The gene discussed is IL33; the disease is neoplasm.